
无数据
无数据
无数据
| CAS Number | 520-85-4 |
| Catalog Number | AG00DEBJ(AGN-PC-0OBMO1) |
| Chemical Name | Medroxyprogesterone |
| EC Number | 208-298-6 |
| IUPAC Name | (6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one |
| InChI | InChI=1S/C22H32O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h12-13,16-18,25H,5-11H2,1-4H3/t13-,16+,17-,18-,20+,21-,22-/m0/s1 |
| InChI Key | FRQMUZJSZHZSGN-HBNHAYAOSA-N |
| MDL Number | MFCD00069474 |
| Molecular Formula | C22H32O3 |
| Molecular Weight | 344.4877 |
| NSC Number | 27408 |
| SMILES | CC([C@@]1(O)CC[C@@]2([H])[C@]3([H])C[C@H](C)C4=CC(CC[C@]4(C)[C@@]3([H])CC[C@]12C)=O)=O |
| UNII | HSU1C9YRES |
| Synonyms | 17 alpha Hydroxy 6 alpha Methylprogesterone,
17 alpha-Hydroxy-6 alpha-Methylprogesterone,
Adgyn Medro,
Medroxyprogesterone,
Methylhydroxyprogesterone,
medroxyprogesterone,
520-85-4,
Medroxyprogesteron,
Medroxiprogesteronum,
Medroxiprogesterona,
Medroxyprogesteronum,
Hydroxymethylprogesterone,
Medrossiprogesterone,
17-Hydroxy-6alpha-methylprogesterone,
Medrossiprogesterone [DCIT],
17alpha-Hydroxy-6alpha-methylprogesterone,
Medroxyprogesteronum [INN-Latin],
Medroxiprogesterona [INN-Spanish],
6alpha-Methyl-17alpha-hydroxyprogesterone,
Medroxyprogesterone [INN:BAN],
UNII-HSU1C9YRES,
6alpha-Methyl-4-pregnen-17alpha-ol-3,20-dione,
17-Hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione,
U 8840,
HSDB 3114,
6-alpha-Methyl-17-alpha-hydroxyprogesterone,
HSU1C9YRES,
EINECS 208-298-6,
NSC 27408,
BRN 2510965,
(6alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione,
MLS000069571,
CHEBI:6715,
(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one,
17alpha-Hydroxy-6alpha-methyl-4-pregnene-3,20-dione,
CPD000058769,
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)-,
SMR000058769,
DSSTox_CID_16508,
DSSTox_RID_79284,
DSSTox_GSID_36508,
Pregn-4-ene-3,20-dione, 17-hydroxy-6-alpha-methyl-,
Novo-Medrone,
17-Hydroxy-6.alpha.-methylprogesterone,
6-Dihydromegestrol,
CAS-520-85-4,
17.alpha.-Hydroxy-6.alpha.-methylprogesterone,
6.alpha.-Methyl-17.alpha.-hydroxyprogesterone,
MPA Gyn 5,
MLS002639162,
Medroxyprogesteron acetate,
Farlutal inyectable (TN),
Medroxyprogesterone (INN),
NCGC00183122-01,
CBP-1011,
Medroxy Progesterone,
Medroxyprogesterone Base,
Opera_ID_433,
AC1L1VM7,
CHEMBL1390,
6alpha-Methyl-5-pregnen-17alpha-ol-3,20-dione,
SCHEMBL37494,
4-08-00-02211 (Beilstein Handbook Reference),
MLS001076098,
MLS001424229,
GTPL2879,
DTXSID0036508,
CTK8G0768,
17-Hydroxy-6a-methylprogesterone,
HMS2052A13,
HMS2230B08,
HY-B0648,
NSC27408,
ZINC5763835,
Tox21_113401,
3808AH,
LMST02030176,
MFCD00069474,
NSC-27408,
AKOS015961681,
Tox21_113401_1,
ACN-051087,
CCG-101111,
CS-2882,
NC00361,
MRF-0000022,
NCGC00023064-04,
NCGC00023064-05,
AC-14528,
SAM001246906,
SC-19789,
ST082267,
AB0106039,
LS-118713,
M3113,
17|A-Hydroxy-6|A-methylprogesterone;U8840,
C07119,
D08166,
Pregn-4-ene-3, 17-hydroxy-6.alpha.-methyl-,
120128-EP2292592A1,
120128-EP2298778A1,
520M854,
C-52992,
(6?)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione,
Medroxyprogesterone, VETRANAL(TM), analytical standard,
Pregn-4-ene-3, 17-hydroxy-6-methyl-, (6.alpha.)-,
Pregn-4-ene-3,20-dione,17-hydroxy-6-methyl-, (6a)-,
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6-alpha)-,
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)- (9CI),
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6-alpha)- (9CI),
(1S,8S,11S,15S,2R,10R,14R)-14-acetyl-14-hydroxy-2,8,15-trimethyl-5-oxotetracyc lo[8.7.0.0<2,7>.0<11,15>]heptadec-6-ene,
(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one,
Medroxyprogesterone acetate Related Compound B, United States Pharmacopeia (USP) Reference Standard,
Curretab,
Farlutal,
Amen,
Asconale,
Colirest,
Hematrol,
Lunelle,
Provera,
g-Farlutal,
Adgyn Medro,
Gestapuran,
Metigestrona,
Progestalfa,
Clinofem,
Clinovir,
Farlutin,
Indivina,
Lutopolar,
Nadigest,
Perlutex,
Prodasone,
Progevera,
Proverone,
Ralovera,
Repromap,
Repromix,
Sirprogen,
Sodelut G,
Aragest,
Lutoral,
Meprate,
Nidaxin,
Oragest,
Veramix,
Cycrin,
Hysron,
Depo-progestin,
Depo-clinovir,
Depo-Prodasone,
Depo-Promone,
Depo-Provera,
Perlutex Leo,
Med-Pro,
Aragest 5,
Farlutal inyectable,
Methylhydroxyprogesterone,
DMPA,
Medroprogesterone Acetate,
Depo-Subq Provera 104,
Medroxyprogesterone acetate,
D0I2SD,
C22H32O3,
Depot-medroxyprogesterone acetate,
Medroxyprogesterone Strakan Brand,
CID10631,
Strakan Brand of Medroxyprogesterone,
Medroxyprogesterone - 100MG 100mg,
C22-H32-O3,
CS-O-01885,
17 alpha Hydroxy 6 alpha Methylprogesterone,
17 alpha-Hydroxy-6 alpha-Methylprogesterone,
17-alpha-hydroxy-6-alpha-methylprogesterone,
D008525,
(6-alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione,
Pregn-4-ene-3, 20-diona, 17-hidroxi-6-metil-, (6alfa)-,
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6.alpha.)-,
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6-alpha)-(9CI),
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)-(9CI),
MAP,
MP,
MPA,
|
| Complexity | 664 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 7 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 344.235g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 25 |
| Hydrogen Bond Acceptor Count | 3 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 344.495g/mol |
| Monoisotopic Mass | 344.235g/mol |
| Rotatable Bond Count | 1 |
| Topological Polar Surface Area | 54.4A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3.5 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302-H335 |
| Packing Group | |
| Precautionary statements | P261 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

